Literature DB >> 28741502

Immune Priming of the Tumor Microenvironment by Radiation.

Wen Jiang1, Charles K Chan2, Irving L Weissman2, Betty Y S Kim3, Stephen M Hahn4.   

Abstract

Ionizing irradiation can induce a multitude of alterations within the tumor microenvironment. Unlike targeted therapies, radiation delivered to the tumor bed can prompt phenotypic changes in both normal stromal and cancer cells, leading to molecular and physiological alterations within the tumor microenvironment. These environmental modulations directly influence the degree of immunogenicity of the tumor microenvironment and may ultimately affect tumor responsiveness to cancer immunotherapies. Here we review the preclinical evidence for tumor microenvironment-mediated immune suppression and how radiation can modulate immune properties within a tumor. We then discuss the therapeutic opportunities for combining radiation with molecular agents to enhance tumor immunogenicity and how this represents a potential exciting strategy to complement immunotherapies including immune checkpoint blockers in cancer treatment.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  abscopal effect; cancer immunotherapy; immune checkpoint inhibitor; immunogenic cell death; radioimmunotherapy; radiotherapy; tumor microenvironment

Mesh:

Year:  2016        PMID: 28741502     DOI: 10.1016/j.trecan.2016.09.007

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  50 in total

Review 1.  Noninvasive PET Imaging of T cells.

Authors:  Weijun Wei; Dawei Jiang; Emily B Ehlerding; Quanyong Luo; Weibo Cai
Journal:  Trends Cancer       Date:  2018-04-17

2.  The Proteomic Effects of Pulsed Focused Ultrasound on Tumor Microenvironments of Murine Melanoma and Breast Cancer Models.

Authors:  Omer Aydin; Parwathy Chandran; Rebecca R Lorsung; Gadi Cohen; Scott R Burks; Joseph A Frank
Journal:  Ultrasound Med Biol       Date:  2019-09-14       Impact factor: 2.998

3.  An autoimmune-based, paraneoplastic neurologic syndrome following checkpoint inhibition and concurrent radiotherapy for merkel cell carcinoma: case report.

Authors:  Alexander D Sherry; Michael Bezzerides; Mohamed H Khattab; Guozhen Luo; Kristin K Ancell; Austin N Kirschner
Journal:  Strahlenther Onkol       Date:  2020-01-31       Impact factor: 3.621

Review 4.  The Reciprocity between Radiotherapy and Cancer Immunotherapy.

Authors:  Yifan Wang; Zhi-Gang Liu; Hengfeng Yuan; Weiye Deng; Jing Li; Yuhui Huang; Betty Y S Kim; Michael D Story; Wen Jiang
Journal:  Clin Cancer Res       Date:  2018-11-09       Impact factor: 12.531

5.  Integrating Radiosensitivity and Immune Gene Signatures for Predicting Benefit of Radiotherapy in Breast Cancer.

Authors:  Yi Cui; Bailiang Li; Erqi L Pollom; Kathleen C Horst; Ruijiang Li
Journal:  Clin Cancer Res       Date:  2018-06-19       Impact factor: 12.531

Review 6.  Genomics-Guided Immunotherapy for Precision Medicine in Cancer.

Authors:  Shradha Mukherjee
Journal:  Cancer Biother Radiopharm       Date:  2019-07-16       Impact factor: 3.099

Review 7.  Host tissue determinants of tumour immunity.

Authors:  Hélène Salmon; Romain Remark; Sacha Gnjatic; Miriam Merad
Journal:  Nat Rev Cancer       Date:  2019-04       Impact factor: 60.716

Review 8.  Improving immune-vascular crosstalk for cancer immunotherapy.

Authors:  Yuhui Huang; Betty Y S Kim; Charles K Chan; Stephen M Hahn; Irving L Weissman; Wen Jiang
Journal:  Nat Rev Immunol       Date:  2018-01-15       Impact factor: 53.106

9.  Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell-mediated remissions.

Authors:  Suparna Dutt; Michelle B Atallah; Yoshitaka Minamida; Alexander Filatenkov; Kent P Jensen; Bettina P Iliopoulou; Rasa Tamosiuniene; Jeffrey Waters; Edgar G Engleman; Samuel Strober
Journal:  Blood Adv       Date:  2018-10-09

Review 10.  B7-H3-targeted Radioimmunotherapy of Human Cancer.

Authors:  Benjamin B Kasten; Soldano Ferrone; Kurt R Zinn; Donald J Buchsbaum
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.